49 results
8-K
EX-99.1
CHRS
Coherus Biosciences Inc
7 Oct 16
Coherus BioSciences Announces FDA Acceptance of 351(k) Biologics
12:00am
for major regulated markets. Biosimilars are intended for use in place of existing, branded biologics to treat a range of chronic and often life-threatening
8-K
EX-99.1
CHRS
Coherus Biosciences Inc
8 Jul 19
Results of Operations and Financial Condition
4:11pm
for use in place of existing, branded biologics to treat a range of chronic and often life-threatening diseases, with the potential to reduce costs
8-K
EX-99.1
zj32hs
6 Aug 20
Coherus BioSciences Appoints Kimberly Tzoumakas, J.D. to Board of Directors
4:19pm
8-K
EX-99.1
p0dwn8b5 3b339ewq
3 May 18
Other Events
5:21pm
8-K
EX-99.1
h3rhfo3hxeq1go0qx
3 May 19
Entry into a Material Definitive Agreement
4:02pm
8-K
EX-99.1
5orirymb
5 Apr 19
Coherus BioSciences Announces Unaudited First Quarter 2019 UDENYCA™ Net Sales
4:13pm
8-K
EX-99.1
jl2b1
6 Oct 16
Coherus BioSciences Completes two
12:00am
8-K
EX-99.1
tuxwn 72hlka44
15 May 18
Other Events
12:00am
8-K
EX-99.1
hqf6gi
31 Jul 18
Other Events
4:06pm
8-K
EX-99.1
wl5j 0yqma2
14 May 18
Departure of Directors or Certain Officers
5:22pm
8-K
EX-99.1
lngq elmfu1znqhq
25 May 18
Coherus Announces Proposed Public Offering of Common Stock
4:01pm
8-K
EX-99.2
s2aldmilu4alm356y
25 May 18
Coherus Announces Proposed Public Offering of Common Stock
4:01pm
8-K
EX-99.1
wiqd 8vvotrbmwjxmdm
17 Apr 20
Coherus BioSciences Announces Proposed Convertible Senior Subordinated Notes Offering
4:24pm
8-K
EX-99.1
t9gi62brw4c8ds
2 Nov 18
Other Events
4:05pm
8-K
EX-99.1
825y2xnhz8nu
19 Mar 19
Coherus BioSciences Receives Transitional
4:05pm